Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-alpha: a biomarker of compound-induced skeletal muscle toxicity in the rat.
about
Use of proteomic analysis to monitor responses to biological therapies.Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry.Use of proteomics for the discovery of early markers of drug toxicity.Pharmacoproteomics in drug development.What is next in pharmacogenomics? Translating it to clinical practice.Effects of anesthetics pentobarbital sodium and chloral hydrate on urine proteome.Toxicoproteomics: proteomics applied to toxicology and pathology.Multiplex approaches in protein microarray technology.Prediction of urinary protein markers in lupus nephritisUse of proteomic methods in the analysis of human body fluids in Alzheimer research.Urinary biomarkers in hexachloro-1:3-butadiene-induced acute kidney injury in the female Hanover Wistar rat; correlation of α-glutathione S-transferase, albumin and kidney injury molecule-1 with histopathology and gene expression.Dose response and time course studies on superoxide dismutase as a urinary biomarker of carbon tetrachloride-induced hepatic injury in the Hanover Wistar rat.Fabp3 as a biomarker of skeletal muscle toxicity in the rat: comparison with conventional biomarkers.Comprehensive characterization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride-induced model of hepatic fibrosis in the female Hanover Wistar rat.Use of proteomics for the discovery of early markers of drug toxicityCurrent awareness on comparative and functional genomics
P2860
Q33196034-CEAAD64E-7E65-45DC-B9C4-0BBDEE83BCCDQ33219779-405DEA40-046B-4AF3-B368-03C5A1639E51Q33269263-337EC0E0-8609-47C8-A741-575901E27300Q34698617-1C95E9C0-603F-40F4-846E-C75465C3295DQ35127370-EDB06EE4-29CA-4900-B0CF-003BFDE3F8A8Q35164680-E98F556C-AB05-4836-BDB1-7F271BA5760BQ35184085-4E674FE1-F650-40A9-9516-ABC7716EA3FFQ35973576-B0760896-DEB4-4515-BE6A-0A26A2221F6FQ36227932-6554BFC1-0620-40F4-AF79-17A89693229DQ37155149-0ED014E3-1991-43DA-9CD0-B620C76B13E1Q38060574-97DCE0C8-D3E0-43C9-9842-7FA70A332D80Q42755579-4F58DF94-1E05-4601-B588-C384D08A3997Q43274556-66A8939E-8ED2-4521-86CE-12B792FA3696Q46727130-3729A530-4C5B-4991-BA52-2E601F1F0C72Q51736939-29A04675-7B65-494D-847A-61E480A50E59Q54246969-10B1AA40-9EAF-4C68-960D-A0E2DEBEFD11Q57953579-1E659C8A-FDF4-4984-BAB5-24CFEDBBB839
P2860
Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-alpha: a biomarker of compound-induced skeletal muscle toxicity in the rat.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Application of surface-enhance ...... al muscle toxicity in the rat.
@ast
Application of surface-enhance ...... al muscle toxicity in the rat.
@en
type
label
Application of surface-enhance ...... al muscle toxicity in the rat.
@ast
Application of surface-enhance ...... al muscle toxicity in the rat.
@en
prefLabel
Application of surface-enhance ...... al muscle toxicity in the rat.
@ast
Application of surface-enhance ...... al muscle toxicity in the rat.
@en
P2093
P1433
P1476
Application of surface-enhance ...... al muscle toxicity in the rat.
@en
P2093
Huw A Davies
John A Turton
Malcom J York
Theo O Dare
Thomas C Williams
P2860
P304
P356
10.1002/1522-2683(200209)23:18<3241::AID-ELPS3241>3.0.CO;2-D
P577
2002-09-01T00:00:00Z